← Back

Industrifonden

Europe HQ Seed Series-A
Cheque range
£750k – £3.8M
Stages
Seed, Series A
Avg deals / year
–
Leads rounds
Yes
HQ
Stockholm, Sweden
Fund type
Venture fund

01 · Thesis & focus

Evergreen Swedish venture capital fund founded in 1979 and based in Stockholm. It backs Nordic companies from seed to Series A across life science, deep tech and transformative tech, and lately has also invested in agtech and food-tech.

Sectors (7)

02 · Recent publicly announced deals

OlsAro 🇸🇪 Seed · Oct 2026 · €5M First-cheque stage announcement ↗

Gothenburg agtech firm whose SeedAX platform uses genetics, data and AI-driven trait discovery to develop climate-resilient cereal varieties.

AnaCardio 🇸🇪 Series B · Sep 2026 · €62.5M announcement ↗

Industrifonden took part in AnaCardio's €62.5M Series B.

Founders: Lars L.
EnginZyme 🇸🇪 Series B · Sep 2026 site ↗

Cell-free enzymatic biomanufacturing using immobilised enzymes for sustainable chemicals and ingredients. Solna, Sweden.

Founders: Robin C., Karim C., Samuel H.
Pixelgen Technologies 🇸🇪 Series B · Aug 2026 · $15.5M announcement ↗

Oversubscribed Series B to speed up global expansion and unlock new insights into biology.

Enginio 🇸🇪 Undisclosed · Jun 2026 · SEK 30M announcement ↗

Raised SEK 30M from Industrifonden and leading retail figures to accelerate growth.

Founders: Martin S.
Evam Undisclosed · May 2026 · SEK 38M announcement ↗

Raised SEK 38M from Industrifonden and FSG to build a next-generation public safety platform.

Melt&Marble 🇸🇪 Series A · Dec 2025 · €7.3M First-cheque stage announcement ↗

Swedish biotech making precision-fermented designer fats for food and personal care; Industrifonden led the round.

Founders: Anastasia K.
Tribune Therapeutics 🇸🇪 Series A · Mar 2025 · €23M First-cheque stage announcement ↗

Nordic biotech developing CCN5-mimicking anti-fibrotic therapies (lead TRX-44 for IPF)

Founders: Ole K.

03 · Similar firms

Raising? See which European funds fit your round →